Commentary highlights gradual tapering strategies to maintain myopia control and prevent worsening in patients.
Rebound after discontinuation of myopia control treatment is a clinically important issue that may compromise long-term management. This commentary highlights that gradual tapering of treatment, accompanied by regular monitoring, is critical to maintaining long-term stability and minimizing the risk of progression to high myopia.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: